Cardiac Output and Other Hemodynamic Changes With Prone Position in Cervical Myelopathy Patients Undergoing Surgery
Launched by DHRITIMAN CHAKRABARTI · Jan 20, 2017
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Cervical myelopathy patients undergoing surgery in prone position with:
- • ASA Class I , II and III
- • Age between 18 to 65 years
- • Nurick's grade 2 or more
- Exclusion Criteria:
- • Atlanto occipital dislocation and cervicomedullary junction pathology
- • Tumour pathology
- • Diabetic patients
- • Patients positioned prone in the awake state (without induction of anaesthesia)
About Dhritiman Chakrabarti
Dhritiman Chakrabarti is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on ethical practices and regulatory compliance, the organization collaborates with leading healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. Leveraging a patient-centric approach, Dhritiman Chakrabarti aims to facilitate the development of novel therapies and ensure that clinical trials are designed to meet the needs of diverse populations, ultimately contributing to the enhancement of global health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nitin Manohar, MD, DNB, DM
Principal Investigator
National Institute of Mental Health and Neuro Sciences, Bangalore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials